Log In
Print
BCIQ
Print
Print this Print this
 

budesonide/salmeterol (Labazenit)

  Manage Alerts
Collapse Summary General Information
Company Laboratoires SMB S.A.
DescriptionCapsules of powdered budesonide, a corticosteroid, and salmeterol, a long-acting beta-2 adrenergic agonist (LABA), for inhalation
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAsthma
Indication DetailsTreat asthma in adults requiring a combination product containing an inhaled corticosteroid and long-acting beta-2 adrenergic agonist (LABA)
Regulatory Designation

EU - Standard Review (Treat asthma in adults requiring a combination product containing an inhaled corticosteroid and long-acting beta-2 adrenergic agonist (LABA))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today